Mingyi Shi Selected Research

celastrol

1/2019

Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1α/GLUT4 axis-mediated glucose consumption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingyi Shi Research Topics

Disease

27	Insulin Resistance 03/2020 - 12/2009
12	Body Weight (Weight, Body) 03/2020 - 08/2011
12	Obesity 03/2020 - 08/2012
11	Type 2 Diabetes Mellitus (MODY) 02/2020 - 08/2012
7	Hyperglycemia 02/2020 - 01/2016
7	Glucose Intolerance 01/2020 - 10/2012
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 09/2015
3	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2015 - 06/2013
2	Dyslipidemias (Dyslipidemia) 02/2020 - 10/2012
2	Hyperlipidemias (Hyperlipidemia) 02/2020 - 08/2012
2	Pain (Aches) 01/2017 - 06/2013
2	Hyperinsulinism (Hyperinsulinemia) 01/2016 - 12/2013
2	Hypertension (High Blood Pressure) 10/2012 - 08/2012
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Stroke (Strokes) 01/2021
1	Non-alcoholic Fatty Liver Disease 03/2020
1	Alcoholic Fatty Liver 02/2020
1	Stomach Neoplasms (Stomach Cancer) 03/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Osteoporosis 11/2018
1	Chronic Disease (Chronic Diseases) 01/2017
1	Psychological Trauma 01/2017
1	Wounds and Injuries (Trauma) 12/2015
1	Cardiomyopathies (Cardiomyopathy) 03/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2012
1	Overweight 08/2012

Drug/Important Bio-Agent (IBA)

29	GalaninIBA 01/2020 - 12/2009
21	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 03/2013
10	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018 - 06/2011
7	NeuropeptidesIBA 10/2018 - 03/2013
7	Insulin (Novolin)FDA Link 05/2018 - 03/2013
5	Blood Glucose (Blood Sugar)IBA 03/2020 - 12/2014
5	baicalinIBA 02/2020 - 01/2017
4	Peptides (Polypeptides)IBA 01/2020 - 10/2012
4	Proteins (Proteins, Gene)FDA Link 05/2018 - 01/2014
4	Messenger RNA (mRNA)IBA 05/2018 - 12/2014
4	Galanin Receptors (Galanin Receptor)IBA 01/2017 - 03/2013
4	Hormones (Hormone)IBA 12/2015 - 12/2009
2	baicaleinIBA 02/2020 - 01/2018
2	p38 Mitogen-Activated Protein KinasesIBA 11/2019 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2018 - 05/2014
2	Type 1 Galanin ReceptorIBA 01/2018 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 10/2016 - 04/2014
2	alarinIBA 01/2015 - 12/2014
2	AdiponectinIBA 12/2014 - 01/2014
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 12/2014 - 01/2014
1	catalpolIBA 01/2021
1	geniposideIBA 01/2021
1	LipidsIBA 03/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2020
1	Pharmaceutical PreparationsIBA 03/2020
1	San-HuangIBA 03/2020
1	celastrolIBA 01/2019
1	Tartrate-Resistant Acid PhosphataseIBA 11/2018
1	OsteocalcinIBA 11/2018
1	Estrogens (Estrogen)FDA Link 11/2018
1	Alkaline PhosphataseIBA 11/2018
1	Type 2 Galanin ReceptorIBA 01/2018
1	BuffersIBA 01/2017
1	alarin 6-25CysIBA 12/2014
1	2- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA 12/2014
1	Vesicle-Associated Membrane Protein 2 (VAMP2)IBA 12/2014
1	Glucose Transporter Type 4IBA 12/2014
1	Galanin-Like PeptideIBA 01/2014
1	GhrelinIBA 01/2014
1	LigandsIBA 03/2013
1	CholesterolIBA 08/2012

Therapy/Procedure

1	Therapeutics 08/2012